- Home
- JYD vs ENLV Comparison
JYD vs ENLV Comparison
Compare JYD & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- ENLV
- Stock Information
- Founded
- JYD 2001
- ENLV 2005
- Country
- JYD China
- ENLV Israel
- Employees
- JYD N/A
- ENLV N/A
- Industry
- JYD Oil Refining/Marketing
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- JYD Consumer Discretionary
- ENLV Health Care
- Exchange
- JYD Nasdaq
- ENLV Nasdaq
- Market Cap
- JYD 23.3M
- ENLV 23.7M
- IPO Year
- JYD 2023
- ENLV 1995
- Fundamental
- Price
- JYD $0.22
- ENLV $0.94
- Analyst Decision
- JYD
- ENLV Strong Buy
- Analyst Count
- JYD 0
- ENLV 2
- Target Price
- JYD N/A
- ENLV $10.00
- AVG Volume (30 Days)
- JYD 15.2M
- ENLV 54.0K
- Earning Date
- JYD 06-10-2025
- ENLV 06-13-2025
- Dividend Yield
- JYD N/A
- ENLV N/A
- EPS Growth
- JYD N/A
- ENLV N/A
- EPS
- JYD N/A
- ENLV N/A
- Revenue
- JYD $77,444,271.00
- ENLV N/A
- Revenue This Year
- JYD N/A
- ENLV N/A
- Revenue Next Year
- JYD N/A
- ENLV N/A
- P/E Ratio
- JYD N/A
- ENLV N/A
- Revenue Growth
- JYD 13.54
- ENLV N/A
- 52 Week Low
- JYD $0.09
- ENLV $0.81
- 52 Week High
- JYD $8.00
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- JYD 34.25
- ENLV 41.05
- Support Level
- JYD $0.21
- ENLV $0.92
- Resistance Level
- JYD $0.24
- ENLV $1.03
- Average True Range (ATR)
- JYD 0.03
- ENLV 0.05
- MACD
- JYD 0.07
- ENLV -0.01
- Stochastic Oscillator
- JYD 4.56
- ENLV 15.38
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is a end-to-end supply chain solution providers in China, with a focus on providing cross-border logistics services. It offers freight forwarding services, (ii) supply chain management, and (iii) other value-added services.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.